Article Details

Apellis, Beam ink $75M deal to bring gene-editing meds to complement diseases

Retrieved on: 2021-06-30 20:15:00

Tags for this article:

Click the tags to see associated articles and topics

Apellis, Beam ink $75M deal to bring gene-editing meds to complement diseases. View article details on hiswai:

Excerpt

... making waves in gene editing, Beam Therapeutics is swimming in a different direction with the budding technology to help reset the immune system.

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up